Literature DB >> 6283135

RNA-dependent RNA polymerase activity in coronavirus- infected cells.

D E Dennis, D A Brian.   

Abstract

An enzymatic activity which incorporates [3H]UMP into acid-precipitable material in the presence of endogenous template was found in the cytoplasm of porcine cells infected with the transmissible gastroenteritis virus of swine. This activity was not found in uninfected control cells, nor was it found in purified virus. The activity was associated with the mitochondrial fraction of infected cells, suggesting that the enzyme is membrane bound. The activity required the presence of all three ribonucleoside triphosphates in addition to [3H]UTP, and it was not inhibited by actinomycin D. The heated product was digested by RNase but not by DNase. Mg2+ was required for enzymatic activity, and its optimal concentration was approximately 5 mM. The size of the in vitro products was compared by electrophoresis with that of in vivo-synthesized virus-specified RNA to confirm the viral specificity of the polymerase activity. Virus-specified RNA from infected cells consisted of 10 species of single-stranded, polyadenylated RNA with molecular weights of 6.8 X 10(6), 6.2 X 10(6), 3.15 X 10(6), 1.40 X 10(6), 1.05 X 10(6), 0.94 X 10(6), 0.66 X 10(6), 0.39 X 10(6), 0.34 X 10(6), and 0.24 X 10(6). In vitro synthesized RNA consisted of a high-molecular-weight species, of apparently higher molecular weight than genomic RNA, and two single-stranded species that electrophoretically comigrated with the species of 1.40 X 10(6) and 0.66 X 10(6) molecular weight made in vivo.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283135      PMCID: PMC256056     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Soluble RNA polymerase complex from poliovirus-infected HeLa cells.

Authors:  E Ehrenfeld; J V Maizel; D F Summers
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

2.  Properties of a virus-induced RNA polymerase in ascites cells infected with encephalomyocarditis virus.

Authors:  E Horton; S L Liu; E M Martin; T S Work
Journal:  J Mol Biol       Date:  1966-01       Impact factor: 5.469

3.  Studies on transmissible gastroenteritis of swine. II. Selected characteristics of a cytopathogenic virus common to five isolates from transmissible gastroenteritis.

Authors:  A W McClurkin; J O Norman
Journal:  Can J Comp Med Vet Sci       Date:  1966-07

4.  The isolation of two enzyme-ribonucleic acid complexes involved in the synthesis of foot-and-mouth disease virus ribonucleic acid.

Authors:  R B Arlinghaus; J Polatnick
Journal:  Proc Natl Acad Sci U S A       Date:  1969-03       Impact factor: 11.205

5.  Detergent-solubilized RNA polymerase from cells infected with foot-and-mouth disease virus.

Authors:  R B Arlinghaus; J Polatnick
Journal:  Science       Date:  1967-12-08       Impact factor: 47.728

6.  Characterization of the products formed by the RNA polymerases of cells infected with encephalomyocarditis virus.

Authors:  L Dalgarno; E M Martin; S L Liu; T S Work
Journal:  J Mol Biol       Date:  1966-01       Impact factor: 5.469

Review 7.  Symposium on replication of viral nucleic acids. 3. Replication of mengovirus ribonucleic acid.

Authors:  P G Plagemann; H E Swim
Journal:  Bacteriol Rev       Date:  1966-06

8.  Sindbis virus-induced viral ribonucleic acid polymerase.

Authors:  T Sreevalsan; F H Yin
Journal:  J Virol       Date:  1969-06       Impact factor: 5.103

9.  Ribonucleic acid polymerase in virions of Newcastle disease virus: comparison with the vesicular stomatitis virus polymerase.

Authors:  A S Huang; D Baltimore; M A Bratt
Journal:  J Virol       Date:  1971-03       Impact factor: 5.103

10.  Ribonucleic acid polymerase catalyzing synthesis of double-stranded arbovirus ribonucleic acid.

Authors:  E M Martin; J A Sonnabend
Journal:  J Virol       Date:  1967-02       Impact factor: 5.103

View more
  28 in total

1.  Diagnosis of porcine and bovine enteric coronavirus infections using cloned cDNA probes.

Authors:  L J Shockley; P A Kapke; W Lapps; D A Brian; L N Potgieter; R Woods
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

Review 2.  RNA recombination in animal and plant viruses.

Authors:  M M Lai
Journal:  Microbiol Rev       Date:  1992-03

3.  Minus-strand copies of replicating coronavirus mRNAs contain antileaders.

Authors:  P B Sethna; M A Hofmann; D A Brian
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

4.  Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes.

Authors:  A C Sims; J Ostermann; M R Denison
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Characterization of coronavirus RNA polymerase gene products.

Authors:  J Herold; S Siddell; J Ziebuhr
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

6.  Coronavirus genomic and subgenomic minus-strand RNAs copartition in membrane-protected replication complexes.

Authors:  P B Sethna; D A Brian
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons.

Authors:  P B Sethna; S L Hung; D A Brian
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

8.  Characterization and translation of transmissible gastroenteritis virus mRNAs.

Authors:  L Jacobs; B A van der Zeijst; M C Horzinek
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

9.  Characterization of the expression, intracellular localization, and replication complex association of the putative mouse hepatitis virus RNA-dependent RNA polymerase.

Authors:  Sarah M Brockway; Corrie T Clay; Xiao Tao Lu; Mark R Denison
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis.

Authors:  S G Sawicki; D L Sawicki
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.